Profesör Doktor MUSTAFA ÇETİNER

Eğitim

2000 Marmara Üniversitesi Tıp Fakültesi Hematoloji
1994 Karadeniz Teknik Üniversitesi Tıp Fakültesi İç Hastalıkları
1988 Ankara Üniversitesi Tıp Fakültesi

İş Deneyimi

2019 Acıbadem Sağlık Grubu
2016 - 2019 Koç Üniversitesi Tıp Fakültesi İç Hastalıkları Ana Bilim Dalı Başkanı
2016 - 2019 Koç Üniversitesi Tıp Fakültesi İç Hast. Anabilim Dalı kurucusu ve Başkanı
2013 - 2019 Koç Üniversitesi Tıp Fakültesi İç Hastalıkları Koordinatörü
2008 - 2017 Amerikan Hastanesi Terapötik Aferez Sorumlu Hekimi
2013 Koç Üniversitesi Tıp Fakültesi / Profesör
2010 - 2013 Şişli Memorial Hastanesi Kemik İliği Nakli Ünitesi Direktörü
2011 - 2012 Şişli Memorial Hastanesi Kemik İliği Nakli Ünitesi kurucusu ve Direktörü / Doçent
2010 WHO (Dünya Sağlık Örgütü) ve UN (Birleşmiş Milletler) Hekimi
2008 V.K.V. Amerikan Hastanesi Hematoloji Bölümü / Doçent
2006 - 2008 Marmara Üniversitesi / İç Hastalıkları / Hematoloji / Doçent
2001 - 2006 Marmara Üniversitesi / İç Hastalıkları / Hematoloji / Yardımcı Doç.
2004 - 2005 Hematopetic Stem Cell Transplantation Program / Department of Medicine / Feinberg School of Medicine / Northwestern University / Misafir Öğretim Üyesi
1998 - 2001 Marmara Üniversitesi / İç Hastalıkları / Hematoloji / Uzman Dr.
1997 - 2000 Marmara Üniversitesi Tıp Fakültesi / İç Hastalıkları / Hematoloji / Dr.Ar.Gör.
1994 - 1997 Milli Eğitim Bakanlığı Beşevler Sağlık Eğitim Merkezi / Uzman Dr.
1989 - 1994 İç Hastalıkları Tıp Fakültesi Karadeniz Teknik Üniversitesi / Dr.Ar.Gör.

Üyelikler

Türk Tabipleri Birliği
Kanser Savaşçıları Derneği
European Hematology Association
American Society of Hematology
European Bone Marrow Transplantation Registry
Türk İç Hastalıkları Uzmanlık Derneği
Türk Hematoloji Derneği
MDS Foundation
Türk İmmünoloji Derneği
Üniversite Öğretim Üyeleri Derneği
Kök Hücre ve Rejeneratif Tıp Derneği
Türk Tromboz ve Hemostaz Derneği

BİLİMSEL YAYINLAR

A multi-centric study on the efficacy of eltrombopag in management of refractory chronic immune thrombocytopenia Turk J Haematol. 2019 Jul 22. doi: 10.4274/tjh.galenos.2019.2018.0307. Cekdemir D, Guvenc S, Ozdemirkiran F, Eser A, Toptas T, Ozkocaman V, Haydaroglu Sahin H, Ermis Turak E, Esen R, Comert M, Sadri S, Aslaner M,
The role of atopy in the pathogenesis of bleomycin pulmonary toxicity Respiratory Medicine. (2019) Ozyigit, L. P., Aktas, E. C., Senbas, Z. A., Ozturk, A. B., Ozturk, E., Ergonul, M. Tabak L, Ferhanoglu B, Cetiner M, Deniz G.
Rituximab desensitization in three patients with severe rituximab allergy. Curr Probl Cancer. 2017 Sep- Oct;41(5): 349-354 Öztürk E, Özyiğit LP, Öztürk AB, Akay MO, Çetiner M, Ferhanoğlu B.
Use of fluorodeoxyglucose positron emission tomography for diagnosis of bleomycin-induced pneumonitis in Hodgkin lymphoma Leuk Lymphoma. 2017 May;58(5):1114-1122 Falay O, Öztürk E, Bölükbaşı Y, Gümüş T, Örnek S, Özbalak M, Çetiner M, Demirkol O, Ferhanoğlu B.
Implementation of an antimicrobial stewardship program for patients with febrile neutropenia Am J Infect Control. 2017 Nov 22. pii: S0196-6553(17) 31136-7. doi: 10.1016/j.ajic.2017.09.030. [Epub ahead of print] Madran B, Keske Ş, Tokça G, Dönmez E, Ferhanoğlu B, Çetiner M, Mandel NM, Ergönül Ö
Iron deficiency and anemia in heart failure Turk Kardiyol Dern Ars. 2017 Mar;45(Suppl 2):1-38 Çavuşoğlu Y, Altay H, Çetiner M, Güvenç TS, Temizhan A, Ural D, Yeşilbursa D, Yıldırım N, Yılmaz MB.
Diagnosis and treatment of iron deficiency anemia in patients with inflammatory bowel disease and gastrointestinal bleeding: iron deficiency anemia working group consensus report. Akpınar H, Çetiner M, Keshav S, Örmeci N, Törüner M.
Complete Remission of Burkitt Lymphoma After Surgical Excision: A Case Report. Indian J Hematol Blood Transfus. 2016 Jun;32(Suppl 1):178-80 Bekoz HS, Kantarcioglu B, Tecimer T, Uskent N, Cetiner M, Ferhanoglu B, Sargin D.
Comparison of International Prognostic Index and NCCN-IPI in 324 patients with de novo diffuse large B-cell lymphoma: a multi-center retrospective analysis. Leuk Lymphoma. 2016 May;57(5):1211-4. Öztürk E, Özbalak M, Berk S, Erdoğan I, Avşar E, Dolgun A, Çetiner M, Mandel NM, Yalnız FF, Elverdi T, Salihoğlu A, Eşkazan AE, Ar MC, Öngören Ş,
Novel Masters of Erythropoiesis: Hypoxia Inducible Factors and Recent Advances in Anemia of Renal Disease. Blood Purif. 2016 Jun 18;42(2):160-167. Solak Y, Cetiner M, Siriopol D, Tarim K, Afsar B, Covic A, Kanbay M.
GnRH agonist leuprolide acetate does not confer any protection against ovarian damage induced by chemotherapy and radiation in vitro Hum Reprod. 2015 Dec;30(12):2912-25. Bildik G, Akin N, Senbabaoglu F, Sahin GN, Karahuseyinoglu S, Ince U, Taskiran C, Selek U, Yakin K, Guzel Y, Ayhan C, Alper E, Cetiner M, Balaban B,
Diagnostic contribution of (18) F-FDG-PET/CT in fever of unknown origin Int J Infect Dis. 2014; 19; 53-8 Tokmak H, Ergönul O, Demirkol O, Cetiner M, Ferhanoglu B
Nonleukemic ureteral granulocytic sarcoma presenting with unilateral urinary obstruction and Hematuria Case Rep Urol. 2013 2013;2013:861232. doi: 10.1155/2013/861232. Epub 2013 Aug 19. Acar O, Esen T, Tecimer T, Cetiner M, Peker O, Musaoğlu A
Cyclosporin A therapy on idiopathic thrombotic thrombocytopenic purpura in relapse setting: two case reports and a review of literature Transfusion. 2013 53 (7): 1586-93 Yilmaz M, Eskazan AE, Unsal A, Taninmis H, Kara E, Cetiner M, Ferhanoglu B.
Azacitidine has limited activity in `real life'' patients with MDS and AML: a single centre experience Hematol Oncol 2011; 29: 1?6 Ozbalak M, Cetiner M, Bekoz H, Atesoglu EB, Ar C, Salihoglu A, Tuzuner N, Ferhanoglu B.
Osteonecrosis of the jaw in patients with multiple myeloma treated with zoledronic acid J Bone Miner Metab. 2009;27(4):435-43 Cetiner S, Sucak GT, Kahraman SA, Akı SZ, Kocakahyaoglu B, Gultekin SE, Cetiner M, Haznedar R.
Bortezomib: A New Therapeutic Option for POEMS Syndrome Eur J Haematol. 2009 Sep 3. 84(2):175-7 Kaygusuz I, Tezcan H, Cetiner M, Kocakaya O, Uzay A, Bayik M.
L-Carnitine ameliorates methotrexate-induced oxidative organ injury and inhibits leukocyte death Cell Biol Toxicol 22 (1), 47-60, 2006 Şener, G., Eksioglu-Demiralp, E., Cetiner, M., Ercan, F., Şirvancı, S., Gedik, N., Yeğen, BC
Beta-Glucan amoliorates methotrexate-induced oxidative organ injury via its antioxidant and immunomodulatory effects Eur J Pharmacol. 2006 Aug 7;542(1-3):170-8 Şener G, Eksioglu-Demiralp, E, Çetiner M, Ercan F, Yeğen BC.
Tar.ine protects against methotrexate-induced toxicity and inhibits leucocyte death Toxicology and Applied Pharmacology 209 (1), 39-50 (2005) Cetiner, M., Şener, G., Şehirli, Ö., Eksioglu-Demiralp, E., Ercan, F., Şirvancı, S., Gedik, N., Akpolat, S., Tecimer, T., Yeğen, BC
Non-B, non-T Neoplasms with Lymphoblast Morphology: Further Clarification and Classification Am J Surg Pathol, 28, 835-837 (2004). Özdemirli, M., Cetiner, M
Hairy Cell Leukemia in Father and Son Med Oncol, 20, 375-378 (2003). Cetiner, M., Adıgüzel, C., Argon, D., Ratip, S., Ekşioğlu-Demiralp, E., Tecimer, T., Bayık, M.
Effect of Interferon-alpha-2a on Neutrophil Adhesion and Phagocytosis in Chronic Myeloid Leukemia and Behcet?s Disease Clin Rheumatol, 21, 211-214 (2002). Kartı, S., Ovalı, E., Ratip, S., Cetiner, M., Direskeneli, H., Bayık, M., Akoğlu, T
COMPARISON OF TWO CRYOPRESERVATION METHOD ACCORDING TO STEM CELL VIABILITY AND COLONY FORMING CAPACITY International Journal of Hematology and Oncology, 28(4), 171-177. KARTI, S. S., ADIGÜZEL, C., YILMAZ, M., ÇETİNER, M., RATİP, S., EKŞİOĞLU, E., ... & BAYIK, M.
Clinical Microbiological Case: Chronic Disseminated Candidiasis Clinical Microbiology and Infection, 8, 435-436 (2002). Ratip, S., Odabaşı, Z., Kartı, S., Cetiner, M., Yeğen, C., Çerikçioğlu, N., Bayık, M., Korten, V
Effectivness of FLAG chemotheraphy in refractory or relapsed acute myeloid leukemia Turk. J. Haematol, 18, 53-58.(2001) Ratip, S., Eryüksel, E., Odabaşı, Z., Çetiner, M., Özen, Y., Ovalı, E., ... & Bayık, M.
Normal Pressure Hydrocephalus Associated with Chronic Alpha Interferon Treatment: A Case Report Turk J Haematol, 17(1), 33-35.(2000) Ratip, S., Budak-Alpdoğan, T., Alpdoğan, Ö., Çetiner, M., Karti, S., ELMACI, İ., & Bayik, M.
Effects of Omeprazole on Gallbladder Contraction in Humans Hepatogastroenterology, 47, 346-348 (2000). Kapıcıoğlu, S., Baki, A., Arslan, M., Cetiner, M., Cihanyurdu, N.
Effects of angiotensin converting enzyme inhibitors in healthy rats and in rats with carbon tetrachloride-induced toxic hepatitis Turkish Journal of Medical Sciences, 30(4), 321-326.(2000) OVALI, E., ÇETİNER, M., RATİP, S., AYDIN, F., TEKELİOĞLU, Y., KARTI, S., ... & AĞAOĞLU, N.
Role of Hepatocyte Growth Factor in the Development of Dendritic Cells from CD 34+ Bone Marrow Cells Haematologica, 85, 464-469 (2000). Ovalı, E., Ratip, S., Kibaroğlu, A., Tekelioğlu, Y., Cetiner, M., Kartı, S., Aydın, F., Bayık, M., Akoğlu, T.
Measurement of unconjugated hyperbilirubinemia in Gilbert''s syndrome during compulsory fasting Marmara Medical Journal, 12(4), 171-174.(1999) Kapıcıoğlu, S., Çetiner, M., & Baki, A.
Action of Buffered Aspirin (Alka-Seltzer)''on Gastric Mucosal Injury in Humans Annals of Medical Sciences, 8, 48-51.(1999) Kapicioglu, S., Cetiner, M., & Arslan, M.
Bone marrow transplantation data for marmara university school of medicine: 1989-1998 Marmara Medical Journal, 11(4), 204-209.(1998) Çetiner, M., Ratip, S., Ovalı, E., Kartı, S., Bayık, M., & Akoğlu, T.
The effect of somatostatin analogue (SMS 201-995) on renal function in patients with decompansated cirrhosis and healthy volunteers Turk J Gastroeruerol, 7, 22-26.(1996) CETINER, M., OVALI, E., YIGITER, Y., & KAPICIOGLU, S.

.
.
.

Bize Ulaşın